Main Street Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Main Street Group’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.66K	Sell	7 -18	-72%	-$9.22K	﹤0.01%	692
2026 Q2	$12.4K	Hold	25	–	–	﹤0.01%	519
2026 Q1	$11.2K	Buy	+25	New	+$11.7K	﹤0.01%	525
2025 Q4	–	Sell	-25	Closed	-$9.8K	–	607
2025 Q3	$9.8K	Hold	25	–	–	﹤0.01%	513
2025 Q2	$11.1K	Hold	25	–	–	﹤0.01%	472
2025 Q1	$12.1K	Hold	25	–	–	﹤0.01%	474
2024 Q4	$10.1K	Hold	25	–	–	﹤0.01%	489
2024 Q3	$11.6K	Hold	25	–	–	﹤0.01%	475
2024 Q2	$11.8K	Hold	25	–	–	﹤0.01%	495
2024 Q1	$10.5K	Hold	25	–	–	﹤0.01%	532
2023 Q4	$10.2K	Buy	+25	New	+$9.24K	﹤0.01%	798

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Main Street Group's VRTX Position: Q3 2026 in Review

Main Street Group reduced its Vertex Pharmaceuticals (VRTX) stake by 72% in Q3 2026, selling an estimated $9.22K and leaving 7 shares worth $3.66K. The position accounts for ﹤0.01% of the portfolio, ranked #692.

Main Street Group first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. The position peaked at $12.4K in Q2 2026. 625 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

Main Street Group held 7 shares of Vertex Pharmaceuticals worth $3.66K as of Q3 2026.
Main Street Group sold 18 Vertex Pharmaceuticals shares in Q3 2026, an estimated $9.22K.
Vertex Pharmaceuticals made up ﹤0.01% of Main Street Group's portfolio in Q3 2026, its #692 holding.
Main Street Group first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
Main Street Group's Vertex Pharmaceuticals position peaked at $12.4K in Q2 2026.
625 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Main Street Group's 13F filing for Q3 2026, filed 28 Oct 2026.